If we’re speaking as a Track & Trace community, we need to stop looking only at mature markets and start paying serious attention to what’s unfolding across the African continent.
In a very short time, countries have moved beyond discussion into action but at different speeds and maturity levels. Understanding these statuses is critical:
🔵 𝐏𝐥𝐚𝐧𝐧𝐞𝐝 / 𝐀𝐧𝐧𝐨𝐮𝐧𝐜𝐞𝐝 𝐑𝐨𝐚𝐝𝐦𝐚𝐩𝐬
🟡 𝐏𝐢𝐥𝐨𝐭 / 𝐈𝐧 𝐏𝐫𝐨𝐠𝐫𝐞𝐬𝐬
🟢 𝐄𝐚𝐫𝐥𝐲 𝐈𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧 (𝐌𝐚𝐬𝐭𝐞𝐫 𝐃𝐚𝐭𝐚 / 𝐑𝐞𝐠𝐢𝐬𝐭𝐫𝐚𝐭𝐢𝐨𝐧 𝐏𝐡𝐚𝐬𝐞)
𝐖𝐡𝐚𝐭’𝐬 𝐝𝐫𝐢𝐯𝐢𝐧𝐠 𝐭𝐡𝐢𝐬 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐨𝐧?
1️⃣ WHO Maturity Level (ML3) Ambition
Achieving and sustaining ML3 is no longer optional. It requires real visibility, post-market surveillance, and ultimately… traceability.
2️⃣ The Counterfeit Crisis
This is not theoretical. The scale of falsified medicines in Africa is forcing regulators to act fast.
Track & Trace is not a “future initiative” in Africa… it’s becoming a regulatory reality